1. Morris LG, Sikora AG, Patel SG, et al. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011; 29:739–746.
2. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953; 6:963–968.
3. Yamamoto K, Takano K, Kondo A, et al. Clinical and prognostic analysis of hypopharyngeal squamous cell carcinoma with synchronous and metachronous multiple malignancies. In Vivo. 2018; 32:165–170.
4. Rennemo E, Zätterström U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope. 2008; 118:1350–1356.
5. Kinjo Y, Nonaka S, Oda I, et al. The short-term and long-term outcomes of the endoscopic resection for the superficial pharyngeal squamous cell carcinoma. Endosc Int Open. 2015; 3:E266–E273.
6. Yamaguchi H, Sato H, Tsukahara K, et al. Co-treatment with endoscopic laryngopharyngeal surgery and endoscopic submucosal dissection. Auris Nasus Larynx. 2021; 48:457–463.
7. Atkinson D, Fleming S, Weaver A. Triple endoscopy: a valuable procedure in head and neck surgery. Am J Surg. 1982; 144:416–419.
8. Metzger K, Horn D, Pfeiffer T, et al. Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma? J Craniomaxillofac Surg. 2019; 47:1968–1972.
9. Koerdt S, Raguse JD, Neumann F, et al. Value of panendoscopy in the identification of synchronous malignancies in patients suffering from oral squamous cell carcinoma without clinical signs of a second primary tumor. Anticancer Res. 2021; 41:2039–2044.
10. Noor A, Stepan L, Kao SS, et al. Reviewing indications for panendoscopy in the investigation of head and neck squamous cell carcinoma. J Laryngol Otol. 2018; 132:901–905.
11. Lang K, Menzin J, Earle CC, et al. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg. 2004; 130:1269–1275.
12. Tom MC, Ross RB, Koyfman SA, et al. Clinical factors associated with cost in head and neck cancer: implications for a bundled payment model. J Oncol Pract. 2019; 15:e560–e567.
13. Ono Y, Yao K, Takaki Y, et al. Efficacy of endoscopy under general anesthesia for the detection of synchronous lesions in oro-hypopharyngeal cancer. Clin Endosc. 2023; 56:315–324.